Skip to main content
AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,310.00
+60.00 (0.73%)
Aug 14, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Product Sales (ODM)
1.68B
Log In
Log In
Log In
Log In
Upgrade
Product Sales (ODM) Growth
701.64%
Log In
Log In
Log In
Log In
Upgrade
Product Sales (General)
1.56B
Log In
Log In
Log In
Log In
Upgrade
Product Sales (General) Growth
2430.95%
Log In
Log In
Log In
Log In
Upgrade
Reagent
116.39M
Log In
Log In
Log In
Log In
Upgrade
Reagent Growth
122.50%
Log In
Log In
Log In
Log In
Upgrade
Services
-
Log In
Log In
Log In
Log In
Upgrade
Services Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
South Korea
3.36B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
937.76%
Log In
Log In
Log In
Log In
Upgrade